Navigation Links
CME LLC Announces the Launch of the CME Activity Advances in the Management of Major Depressive Disorders

JERSEY CITY, N.J., Jan. 18, 2012 /PRNewswire/ -- CME LLC has officially launched an online educational activity titled "Advances in the Management of Major Depressive Disorders" on Developed for psychiatrists, primary care physicians, nurses, and other health care professionals, this Case Challenge activity is intended to provide possible treatment options and individualized management approaches, including the augmentation of antidepressant therapy with folate formulations, for consideration when treating patients with major depressive disorder (MDD) in order to provide optimal patient outcomes. This activity is supported by an educational grant from Pamlab, L.L.C.

C. Brendan Montano, MD, the Director of Research at Connecticut Clinical Research, in Cromwell, Connecticut and Richard C. Shelton, MD, a James G. Blakemore Professor in the Department of Psychiatry, Professor in Departments of Psychology and Pharmacology, and Vice-Chair of Clinical Research at Vanderbilt University School of Medicine in Nashville, Tennessee comprise the faculty for the activity.

Cased-based methods of learning are extremely effective in getting across educational messages and demonstrating practical strategies. In this Case Challenge activity, participants are encouraged to determine treatment strategies based on case histories and patient presentations. "Non-response to antidepressant therapy, as defined by the presence or absence of full recovery of depression, is the rule rather than the exception for the treatment of depression, even in the primary care setting. This CME activity presents real-world examples of the management of depression to full remission. As such, I think it will provide practitioners practical strategies for managing depression to wellness." – Richard C. Shelton

Upon completion of the activity, participants should be able to:

  • Utilize evidence-based strategies to best sequence administration of antidepressant therapy with adjunctive therapies to enhance response rates and achieve remission
  • Compare and contrast the long-term efficacy, safety, and tolerability of adjunctive therapies indicated for depression to better individualize therapy
  • Understand the relationship between folate and depression, including the contribution of folate to monoamine deficiencies, to determine patient type
  • Review currently available sources of folate supplementation and their potential role in MDD management

The online activity is CME-certified and approved for nursing contact hours.  It will be available through October 31, 2012. 


CME LLC develops educational plans designed to meet the needs of practicing clinicians based on demonstrated gaps within a target audience. Individual activities focus on maintaining, developing, or increasing the knowledge, skills, competence, and professional performance of clinicians to improve patient care. Founded in 1978 with the vision to provide high-quality, practical medical education and information for mental health clinicians, CME LLC's reach now expands to educational offerings for primary care, oncology, and practice management professionals in various formats including live events, print formats, interactive online activities and more.

Continuing Education Credit

CME LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME LLC designates this enduring activity for a 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Provider approved by the California Board of Registered Nursing, Provider Number CEP12748 for 1 contact hour.

Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion, as AAPA, AANP and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.

Contact: Michael DeMilt
201.984.6224 phone
201.336.6497 fax

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
(Date:10/7/2017)... , Oct. 6, 2017   Provista, ... more than $100 billion in purchasing power, today announced ... and information. The Newsroom is the online ... industry trends, infographics, expert bios, news releases, slideshows and ... access to a wealth of resources at their fingertips, ...
(Date:10/2/2017)... Oct. 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... Software and Consulting, LLC , and named its founder ... based in Tennessee , will operate ... expands EnvoyHealth,s service offerings for health care partners to ... "In an interoperable world, technology ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... ProVest Insurance Group, a family managed ... Raleigh regions, is organizing an extended charity drive to benefit the family of ... , After struggling since birth with several health challenges, T.J. was later diagnosed ...
(Date:10/13/2017)... ... 2017 , ... The International Association of Eating Disorders Professionals ... the field of eating disorders, announces the opening of early registration for the ... at the Omni Resort at ChampionsGate. , The annual iaedp™ Symposium ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers care ... have a waiver for care if the client has a cognitive impairment diagnosis. ... for care, is often waived, so the benefits from their insurance start immediately,” said ...
(Date:10/13/2017)... ... 2017 , ... Talented host, actor Rob Lowe, is introducing ... new episode of "Success Files," which is an award-winning educational program broadcasted on ... subject in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
Breaking Medicine News(10 mins):